State Key Laboratories
State Key Laboratory of Translational Oncology (CUHK)
Located at the Sir YK Pao Centre for Cancer of the Prince of Wales Hospital, the State Key Laboratory of Translational Oncology (CUHK) is built on several solid foundations. One is CUHK's long-established partnership with Sun Yat-sen University in cancer research and the backing of a strong clinical base and support of the Hospital Authority and the then Health and Food Bureau of the Hong Kong SAR Government. With its strong connections to the mainland, the State Key Lab (SKL) is in a good position to extend its scientific achievements to benefit the wider Chinese community and anchor its role in spearheading international collaborations in medical research as well as promoting scientific development of the nation.
Another foundation is the long tradition of cancer research and care in the local community. CUHK's Hong Kong Cancer Institute was established in 1990 to focus activities related to cancer and its problems, and its Comprehensive Cancer Trials Unit (CCTU) was the first in Hong Kong to be approved by the National Cancer Institute (NCI) in the US to conduct new NCI drug clinical studies. The SKL has entered into collaborations with over 20 top cancer trial centres in the world, including MD Anderson, Mayo Clinic, Johns Hopkins University, Oxford University, Fudan University and Peking University.
The investigators of the SKL are a multidisciplinary group of clinical and basic cancer researchers within CUHK and Sun Yat-sen University, who have conducted intensive research investigating the molecular genetics, signalling pathways, clinical diagnostics and novel therapeutic developments of cancers common to our region, in particular nasopharyngeal cancer, liver cancer and gastric cancer.
- Hong Kong Cancer Institute
- Comprehensive Cancer Trials Unit (CCTU)
- Department of Anatomical and Cellular Pathology
- Department of Chemical Pathology